​On 22-24 February, 2023, we hosted our 7th conference RSVVW'23 - A Global Conference on Novel RSV Preventive and Therapeutic Interventions. The aim of the conference was to learn and share knowledge on current research, and to connect worldwide the leading researchers, scientists, physicians, industry, academic scientists, scholars, decision-makers, and representatives from regulatory, global health, and governmental organisations. We look back on an inspiring and successful meeting.
Visit our RSVVW'23 page to find:
- Abstract Booklet
- Scientific Program
​- Photo Gallery
- Session Recordings
- Presentation Slides (Soon Available)
- Company Symposia
​About us​

Donation

PAPER OF THE MONTH

- March 2023 - 

UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants​
Bronchiolitis is an acute respiratory illness that is the leading cause of hospitalization in young children. This document aims to update the consensus document published in 2014 to provide guidance on the current best practices for managing bronchiolitis in infants. The document addresses care in both hospitals and primary care. The diagnosis of bronchiolitis is based on the clinical history and physical examination. The mainstays of management are largely supportive, consisting of fuid management and respiratory support. Evidence suggests no beneft with the use of salbutamol, glucocorticosteroids and antibiotics with potential risk of harm. Because of the lack of efective treatment, the reduction of morbidity must rely on....

ReSViNET STUDIES
​

RSV VACCINATION STUDIES
There are ongoing phase 3 maternal and adult vaccination studies, respectively. 
Phase 3 maternal vaccination study aims to analyse the efficacy of RSVpreF vaccine in infants born to women vaccinated during pregnancy. 
Phase 3 adult vaccination study aims to analyse the efficacy, immunogenicity and safety of the RSVpreF vaccine candidate in 30,000 subjects.​
RSV EPIDEMIOLOGY STUDIES
INFORM and RSV GOLD are ongoing studies to gain insight into RSV Epidemiology. 
​INFORM aims to investigate the worldwide molecular diversity of RSV isolates collected from children less than 5 years of age. 
​RSV GOLD aims to fill gaps in global clinical data on RSV, and hence create a global online database of RSV morality in young children.
MORE STUDIES
PROMISE is a project that works to develop a robust surveillance network on RSV disease, with the goal of strengthening epidemiological and virological surveillance in EUROPE. 
RSV Burden of Disease Study is an observational study of children under the age of two who have been hospitalized with RSV, with the aim of incidence rate  of hospitalizations and burdens associated with  RSV.

ReSViNET GLOBAL PARTNERS
Certified by NGOsource as equivalent to a U.S. public charity
Note: All information on ReSViNET is for educational purposes only. For specific medical advice, diagnoses, and treatment, consult your doctor.

© 2021 ReSViNET Foundation. All rights reserved.
About us
Disclosure
Contact